Nothing Special   »   [go: up one dir, main page]

AU4045097A - Transdermal transport of molecules - Google Patents

Transdermal transport of molecules

Info

Publication number
AU4045097A
AU4045097A AU40450/97A AU4045097A AU4045097A AU 4045097 A AU4045097 A AU 4045097A AU 40450/97 A AU40450/97 A AU 40450/97A AU 4045097 A AU4045097 A AU 4045097A AU 4045097 A AU4045097 A AU 4045097A
Authority
AU
Australia
Prior art keywords
molecules
transdermal transport
transdermal
transport
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40450/97A
Inventor
Wilson T. Crandall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4045097A publication Critical patent/AU4045097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
AU40450/97A 1996-07-23 1997-07-23 Transdermal transport of molecules Abandoned AU4045097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68523596A 1996-07-23 1996-07-23
US08685235 1996-07-23
PCT/US1997/012970 WO1998003641A1 (en) 1996-07-23 1997-07-23 Transdermal transport of molecules

Publications (1)

Publication Number Publication Date
AU4045097A true AU4045097A (en) 1998-02-10

Family

ID=24751308

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40450/97A Abandoned AU4045097A (en) 1996-07-23 1997-07-23 Transdermal transport of molecules

Country Status (4)

Country Link
EP (1) EP0958355A1 (en)
AU (1) AU4045097A (en)
CA (1) CA2262009A1 (en)
WO (1) WO1998003641A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998031369A1 (en) * 1997-01-16 1998-07-23 Sekisui Chemical Co., Ltd. External preparations for percutaneous absorption
US6348450B1 (en) 1997-08-13 2002-02-19 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom and uses thereof
JP2001515052A (en) * 1997-08-13 2001-09-18 ザ ユーエイビー リサーチ ファンデーション Vaccination by local application of gene vectors
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
JP4931128B2 (en) 2003-04-10 2012-05-16 ニューロジェシックス， インコーポレイテッド Methods and compositions for administration of TRPV1 agonists
NZ552816A (en) * 2007-01-24 2009-05-31 Bomac Research Ltd Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
EP2601934A1 (en) * 2009-01-22 2013-06-12 Ludwig-Maximilians-Universität München Vesicular phospholipid gels comprising proteinaceous substances
WO2011156803A2 (en) * 2010-06-11 2011-12-15 Transdel Pharmaceuticals, Inc. Anti-cellulite composition and method of treating cellulite
EP2787973B1 (en) * 2011-12-05 2019-10-09 Incept, LLC Medical organogel processes and compositions
AU2014329412B2 (en) 2013-10-03 2020-02-27 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
JP6891118B2 (en) * 2014-12-23 2021-06-18 インテレクチュアル プロパティ アソシエイツ エルエルシーＩｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ａｓｓｏｃｉａｔｅｓ， ＬＬＣ Methods and formulations for transdermal administration
JP2019502764A (en) * 2016-01-23 2019-01-31 アンパサンド バイオファーマシューティカルズ インコーポレイテッドＡｍｐｅｒｓａｎｄ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． Enhanced transdermal delivery of active agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing

Also Published As

Publication number Publication date
EP0958355A1 (en) 1999-11-24
CA2262009A1 (en) 1998-01-29
WO1998003641A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
AU9790198A (en) Compounds and methods
AU4261697A (en) Compounds and methods
AU5268696A (en) Novel compounds and methods for therapy
AUPO274696A0 (en) Transportable structure
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AUPO625497A0 (en) Analysis of molecules
AU2644497A (en) Biosensors
AU3539297A (en) Transdermal therapeutic systems
AU3011397A (en) Water-stabilized organosilane compounds and methods for using the same
AU4045097A (en) Transdermal transport of molecules
AU5095698A (en) Transdermal patch
AU6657396A (en) Transdermal system
AU9636598A (en) Treatment of organic materials
AU5084498A (en) Wheel support
AU4727297A (en) Novel antitumor compounds and use thereof
AU4302497A (en) Metalocarboxypeptidase inhibitors and derived molecules as antitumoural agents
AU2907597A (en) Paper treatment
AU727267C (en) Patch for transdermal application of pergolid
AU4104997A (en) Therapeutic molecules
AUPO226296A0 (en) Therapeutic molecules
AU6899196A (en) Arginase ii
AU4124497A (en) Treatment of diabetes
AU3532797A (en) Biosensors
AUPO896397A0 (en) Novel molecules and uses thereof-iii
AUPO642097A0 (en) Novel molecules and uses thereof-II